Turning a blind eye: the success of blinding reported in a random sample of randomised, placebo controlled trials
- 22 January 2004
- Vol. 328 (7437) , 432
- https://doi.org/10.1136/bmj.328.74327.37952.631667.ee
Abstract
Objective To examine the reporting and success of double blinding in a sample of randomised, placebo controlled trials from leading general medicine and psychiatry journals. Methods Identification of placebo controlled, randomised controlled trials from prespecified general medical and psychiatric journals indexed on Medline between 1 January 1998 and 1 October 2001, from which a random sample of 200 randomised clinical trials was chosen, of which 191 trials were evaluated. Results Only seven of the 97 (7%) general medicine trials provided evidence on the success of blinding, with five reporting that the success of blinding was imperfect. In trials from psychiatric journals, the success of blinding was reported in eight of the 94 trials, with four reporting that the blinding was imperfect. Overall, only four of the 191 (2%) trials assessed blinding in the participants and either the outcome assessors or the investigators. Conclusions The current lack of reporting on the success of blinding provides little evidence that success of blinding is maintained in placebo controlled trials. Trialists and editors should make a concerted effort to incorporate, report, and publish such information and its potential effect on study results.Keywords
This publication has 20 references indexed in Scilit:
- The Landscape and Lexicon of Blinding in Randomized TrialsAnnals of Internal Medicine, 2002
- Physician interpretations and textbook definitions of blinding terminology in randomized controlled trials.JAMA, 2001
- The Revised CONSORT Statement for Reporting Randomized Trials: Explanation and ElaborationAnnals of Internal Medicine, 2001
- Continuation Pharmacotherapy in the Prevention of Relapse Following Electroconvulsive TherapyJAMA, 2001
- Fludrocortisone Acetate to Treat Neurally Mediated Hypotension in Chronic Fatigue SyndromeJAMA, 2001
- Efficacy and Safety of Recombinant Human Nerve Growth Factor in Patients With Diabetic PolyneuropathyJAMA, 2000
- The Effect of Dietary ω-3 Fatty Acids on Coronary AtherosclerosisAnnals of Internal Medicine, 1999
- Gastrointestinal Symptoms in 3181 Volunteers Ingesting Snack Foods Containing Olestra or Triglycerides for 6 WeeksAnnals of Internal Medicine, 1999
- Nicotine nasal spray with nicotine patch for smoking cessation: randomised trial with six year follow up Commentary: Progress on nicotine replacement therapy for smokersBMJ, 1999
- Acupuncture and Amitriptyline for Pain Due to HIV-Related Peripheral NeuropathyA Randomized Controlled TrialJAMA, 1998